Applied Therapeutics, Inc. - Common Stock (NQ:APLT)
0.4780
-0.1220
(-20.33%)
Streaming Delayed Price
Updated: 2:17 PM EDT, May 19, 2025
Add to My Watchlist
All News about Applied Therapeutics, Inc. - Common Stock


From Applied Therapeutics
Via GlobeNewswire


Applied Therapeutics: Q4 Earnings Insights
March 06, 2024
Via Benzinga

(APLT) - Analyzing Applied Therapeutics's Short Interest
January 25, 2024
Via Benzinga

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
April 01, 2024
Via Benzinga
Exposures
Product Safety


12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via Benzinga


Via Benzinga






FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
February 28, 2024
Via Benzinga
Exposures
Product Safety



Applied Therapeutics Announces $100 Million Private Placement
February 28, 2024
From Applied Therapeutics
Via GlobeNewswire


12 Health Care Stocks Moving In Monday's Intraday Session
February 19, 2024
Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session
February 16, 2024
Via Benzinga

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via Benzinga


Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
January 05, 2024
Via Benzinga
Topics
Stocks


12 Health Care Stocks Moving In Friday's Intraday Session
January 05, 2024
Via Benzinga

Dow Turns Lower; ISM Services PMI Falls In December
January 05, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free